Suchergebnisse - "Pinato, David J"

PubPharm (7)

1

Personalised management of patients with hepatocellular carcinoma : a multiparametric therapeutic hierarchy concept

enthalten in: The Lancet. Oncology | 2023

von Vitale, A. | Cabibbo, G. | Iavarone, M. | +55

2

SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer : results from the OnCovid registry

enthalten in: The Lancet. Oncology | 2023

von Cortellini, A. | Tabernero, J. | Mukherjee, U. | +126

3

COSMIC-312 : mounting immunotherapy enigmas for hepatocellular carcinoma

enthalten in: The Lancet. Oncology | 2022

von Cabibbo, G. | Celsa, C. | D'Alessio, A. | +2

CommentOn: Lancet Oncol. 2022 Aug;23(8):995-1008. - PMID 35798016

4

Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe : results from the retrospective, multicentre, OnCovid registry study

enthalten in: The Lancet. Oncology | 2022

von Pinato, D. | Aguilar-Company, J. | Ferrante, D. | +147

5

Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection : evidence from the OnCovid retrospective, multicentre registry study

enthalten in: The Lancet. Oncology | 2021

von Pinato, D. | Tabernero, J. | Bower, M. | +130

6

Melatonin : resetting the clock of cancer progression?

enthalten in: The Lancet. Oncology | 2016

von Pinato, D. | Stebbing, J.

7

Artemisia : a divine dart against cancer?

enthalten in: The Lancet. Oncology | 2015

von Pinato, D. | Stebbing, J.

1
[1]